Get the Stockscreener App
8.54
4.27%
0.35
After Hours:
8.54
Iteos Therapeutics Inc stock is traded at $8.54, with a volume of 543.17K.
It is up +4.27% in the last 24 hours and down -2.06% over the past month.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.
See More
Previous Close:
$8.19
Open:
$8.26
24h Volume:
543.17K
Relative Volume:
0.79
Market Cap:
$310.17M
Revenue:
$127.70M
Net Income/Loss:
$-108.14M
P/E Ratio:
-10.41
EPS:
-0.82
Net Cash Flow:
$-117.52M
1W Performance:
+8.79%
1M Performance:
-2.06%
6M Performance:
-51.70%
1Y Performance:
-7.38%
1-Day Range:
$8.205
$8.559
1-Week Range:
$7.54
$8.59
52-Week Range:
$7.54
$18.75
Iteos Therapeutics Inc Stock (ITOS) Company Profile
Name
Iteos Therapeutics Inc
Sector
Industry
Phone
857-204-4583
Address
321 ARSENAL STREET, WATERTOWN
Compare ITOS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ITOS
Iteos Therapeutics Inc
|
8.54 | 310.17M | 127.70M | -108.14M | -117.52M | -0.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
464.56 | 119.70B | 10.63B | -479.80M | -1.35B | 13.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
754.87 | 82.75B | 13.85B | 4.65B | 3.32B | 35.06 |
|
ARGX
Argen X Se Adr
|
614.59 | 36.73B | 1.86B | -40.29M | -1.28B | -4.16 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
253.74 | 32.53B | 2.09B | -332.26M | 16.06M | -4.14 |
|
BNTX
Biontech Se Adr
|
120.72 | 28.50B | 3.30B | -501.07M | 1.03B | 11.54 |
Iteos Therapeutics Inc Stock (ITOS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-13-24 | Initiated | Wells Fargo | Overweight |
| May-05-21 | Initiated | H.C. Wainwright | Buy |
| Oct-08-20 | Initiated | Robert W. Baird | Outperform |
| Aug-18-20 | Initiated | JP Morgan | Overweight |
| Aug-18-20 | Initiated | Piper Sandler | Overweight |
| Aug-18-20 | Initiated | SVB Leerink | Outperform |
| Aug-18-20 | Initiated | Wedbush | Outperform |
View All
Iteos Therapeutics Inc Stock (ITOS) Latest News
iTeos Therapeutics, Inc. (NASDAQ:ITOS) Shares Bought by Algert Global LLC - MarketBeat
iTeos annonce sa participation aux prochaines journées Investisseurs - GlobeNewswire Inc.
iTeos to Participate in Upcoming Investor Conferences - GlobeNewswire
iTeos Therapeutics to Present at Evercore and Piper Sandler Healthcare Conferences | ITOS Stock News - StockTitan
GSA Capital Partners LLP Purchases New Holdings in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World
Empowered Funds LLC Increases Stock Holdings in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World
(ITOS) On The My Stocks Page - Stock Traders Daily
Iteos Therapeutics stock hits 52-week low at $7.58 By Investing.com - Investing.com South Africa
Insider Buying: Matthew Gall Acquires 5,000 Shares of ITeos Ther - GuruFocus.com
Iteos Therapeutics stock hits 52-week low at $7.58 - Investing.com
iTeos Therapeutics CFO Matthew Gall acquires $38,635 in common stock - Investing.com India
iTeos Therapeutics CFO Matthew Gall acquires $38,635 in common stock By Investing.com - Investing.com UK
iTeos Therapeutics’ (ITOS) Buy Rating Reiterated at HC Wainwright - Defense World
Equities Analysts Offer Predictions for ITOS FY2024 Earnings - Defense World
US Bancorp DE Has $123,000 Stake in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World
iTeos Therapeutics, Inc. (NASDAQ:ITOS) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year - Simply Wall St
iTeos Therapeutics, Inc. (NASDAQ:ITOS) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year - Yahoo Finance
HC Wainwright Reaffirms Buy Rating for iTeos Therapeutics (NASDAQ:ITOS) - MarketBeat
EcoR1 Capital, LLC Reduces Stake in ITeos Therapeutics Inc - GuruFocus.com
FY2024 EPS Forecast for iTeos Therapeutics Lifted by Analyst - MarketBeat
Iteos Therapeutics stock hits 52-week low at $8.39 - Investing.com
Wedbush Reaffirms Outperform Rating for iTeos Therapeutics (NASDAQ:ITOS) - Defense World
iTeos Therapeutics Reports Q3 2024 Financial Results - TipRanks
Creative Planning Acquires 1,196 Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World
iTeos Reports Third Quarter 2024 Financial Results and Provides Business Updates - GlobeNewswire
iTeos Reports Wider Q3 Loss, Maintains $684M Cash Runway Through 2027 | ITOS Stock News - StockTitan
Iteos Therapeutics stock hits 52-week low at $8.49 - Investing.com India
Iteos Therapeutics stock hits 52-week low at $8.49 By Investing.com - Investing.com South Africa
iTeos Therapeutics to Highlight Inupadenant Preclinical, Translational, and Phase 2 A2A-005 Clinical Trial Data in 2L NSCLC at ESMO Immuno-Oncology Congress - GlobeNewswire
iTeos Therapeutics, Inc. (NASDAQ:ITOS) Shares Purchased by nVerses Capital LLC - Defense World
Iteos Therapeutics stock hits 52-week low at $8.73 - Investing.com India
Iteos Therapeutics stock hits 52-week low at $8.73 By Investing.com - Investing.com Canada
Exchange Traded Concepts LLC Sells 6,414 Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World
(ITOS) Proactive Strategies - Stock Traders Daily
iTeos Therapeutics, Inc. (NASDAQ:ITOS) Stock Position Decreased by AQR Capital Management LLC - MarketBeat
BOXER CAPITAL, LLC Expands Stake in ITeos Therapeutics Inc - GuruFocus.com
ITeos Therapeutics Inc (ITOS) shows promising results - US Post News
Stock Performance Spotlight: ITeos Therapeutics Inc (ITOS) Ends the Day at 9.73, Down by -2.21 - The Dwinnex
ITOS Stock on the Rise: A Promising Investment - The InvestChronicle
Millennium Management LLC Decreases Stake in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World
Millennium Management LLC Lowers Holdings in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - MarketBeat
iTeos Therapeutics, Inc. (NASDAQ:ITOS) Short Interest Update - Defense World
Squarepoint Ops LLC Sells 38,801 Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World
When (ITOS) Moves Investors should Listen - Stock Traders Daily
Did ITeos Therapeutics Inc (ITOS) perform well in the last session? - US Post News
Ratio Revelations: ITeos Therapeutics Inc (ITOS)’s Financial Metrics in the Spotlight - The Dwinnex
TIGITs Trend Upward After iTeos/GSK Present Positive Data at ESMO - BioSpace
Dimensional Fund Advisors LP Raises Position in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - MarketBeat
ITeos TherapeuticsAssessing Breakthrough Therapies To Treat Cancer - RTTNews
A new trading data show ITeos Therapeutics Inc (ITOS) is showing positive returns. - SETE News
American Century Companies Inc. Has $687,000 Holdings in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World
Iteos Therapeutics Inc Stock (ITOS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.35%
0.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):